Which hereditary colorectal cancer syndrome is not primarily associated with an increased risk of small bowel neoplasms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Hereditary diffuse gastric cancer is the syndrome that is not primarily associated with an increased risk of small bowel neoplasms. While several hereditary colorectal cancer syndromes increase the risk of various cancers, the association with small bowel neoplasms varies among them. Lynch syndrome, for instance, is known to increase the risk of colorectal cancer and other cancers such as endometrial, ovarian, gastric, urinary tract, and pancreatic cancers, but it does have an association with small intestinal cancers as noted in the guidelines by 1. In contrast, Hereditary diffuse gastric cancer, primarily associated with an increased risk of gastric cancer, does not have a well-established significant association with small bowel neoplasms compared to the other syndromes listed. Familial Adenomatous Polyposis (FAP) and Juvenile Polyposis syndrome are known for their increased risk of small bowel tumors, making them distinct from Hereditary diffuse gastric cancer in this aspect. The distinction in the risk of small bowel neoplasms among these syndromes is crucial for guiding surveillance strategies and management plans for patients with different hereditary colorectal cancer syndromes, as emphasized by the need for personalized approaches based on the latest guidelines such as those suggested by 1. Key considerations include the type of syndrome, the specific cancers associated with each, and the implementation of appropriate screening and preventive measures to reduce morbidity, mortality, and improve quality of life. Given the information and focusing on the most recent and highest quality evidence, Hereditary diffuse gastric cancer stands out as the syndrome not primarily associated with an increased risk of small bowel neoplasms, which is essential for tailored clinical management and counseling of affected individuals and their families.

From the Research

Hereditary Colorectal Cancer Syndromes and Small Bowel Neoplasms

  • The question asks to identify a hereditary colorectal cancer syndrome that is NOT associated with an increased risk of small bowel neoplasms.
  • The options provided are:
    • A. Lynch syndrome
    • B. Familial adenomatous polyposis
    • C. Hereditary diffuse gastric cancer
    • D. Juvenile polyposis syndrome

Analysis of Options

  • Lynch syndrome 2, 3 and familial adenomatous polyposis 2, 3 are known to be associated with an increased risk of small bowel neoplasms.
  • Juvenile polyposis syndrome is also associated with an increased risk of gastrointestinal neoplasms, including small bowel neoplasms 3.
  • Hereditary diffuse gastric cancer (HDGC) is primarily associated with an increased risk of gastric cancer, particularly diffuse gastric cancer 4, 2, 5, 6, and there is no direct evidence linking it to a significantly increased risk of small bowel neoplasms compared to the other options.

Conclusion Based on Evidence

  • Based on the provided evidence, Hereditary diffuse gastric cancer (HDGC) is the syndrome that is NOT primarily associated with an increased risk of small bowel neoplasms 4, 2, 5, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Genetic Gastric Cancer Risk Syndromes.

Current treatment options in gastroenterology, 2020

Research

Genetic Syndromes Associated with Gastric Cancer.

Gastrointestinal endoscopy clinics of North America, 2022

Research

Hereditary diffuse gastric cancer: diagnosis and management.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2006

Research

Hereditary diffuse gastric cancer.

Advances in cancer research, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.